Current Update on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development with a Special Emphasis on Gene Therapy Viral Vector Design and Construction for Vaccination-Reference-Cited by-同舟云学术

Current Update on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development with a Special Emphasis on Gene Therapy Viral Vector Design and Construction for Vaccination

Published:2021-06-01 Issue:11-12 Volume:32 Page:541-562
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Bisgin Atil¹²,Sanlioglu Ahter D.¹,Eksi Yunus Emre¹,Griffith Thomas S.³,Sanlioglu Salih¹^ORCID

Affiliation:

1. The Department of Gene and Cell Therapy, Faculty of Medicine, Akdeniz University, Antalya, Turkey.

2. Department of Medical Genetics, Faculty of Medicine, Cukurova University, Adana, Turkey.

3. The Department of Urology, School of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/hum.2021.052

Reference169 articles.

1. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China

2. A Novel Coronavirus from Patients with Pneumonia in China, 2019

3. A pneumonia outbreak associated with a new coronavirus of probable bat origin

4. High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2

5. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene and cell therapy of human genetic diseases: Recent advances and future directions;Journal of Cellular and Molecular Medicine;2024-09

2. New Generation Self-Replicating RNA Vaccines Derived from Pestivirus Genome;Methods in Molecular Biology;2024

3. Development and qualification of cell-based relative potency assay for a human respiratory syncytial virus (RSV) mRNA vaccine;Journal of Pharmaceutical and Biomedical Analysis;2023-09

4. Generation of New Live Attenuated Vaccine Strains of Duck Plague Virus and Evaluation of Duck Immune Efficacy;2023

5. Case report: Myocarditis following COVID-19 protein subunit vaccination;Frontiers in Cardiovascular Medicine;2022-09-07